BBCMF (Lir Life Sciences) ROCE %: -594.35% (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences ROCE %?

Lir Life Sciences BBCMF -80.00% 15 ROCE % is -594.35% as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Lir Life Sciences's annualized ROCE % for the quarter that ended in Jan. 2026 was -594.35%.

Lir Life Sciences  (OTCPK:BBCMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Lir Life Sciences ROCE % Related Terms

Lir Life Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences ROCE % Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
ROCE %
0.00 0.00

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROCE % Get a 7-Day Free Trial 0.00 0.00 0.00 -42.99 -594.35
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences ROCE % Calculation

Lir Life Sciences's annualized ROCE % for the fiscal year that ended in Apr. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Apr. 2025 )  (A: Apr. 2024 )(A: Apr. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Apr. 2025 )  (A: Apr. 2024 )(A: Apr. 2025 )
=-0.303/( ( (0.15 - 0.17) + (0.087 - 0.145) )/ 2 )
=-0.303/( (-0.02+-0.058)/ 2 )
=-0.303/-0.039
=776.92 %

Lir Life Sciences's ROCE % of for the quarter that ended in Jan. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jan. 2026 )  (Q: Oct. 2025 )(Q: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jan. 2026 )  (Q: Oct. 2025 )(Q: Jan. 2026 )
=-5.468/( ( (1.107 - 0.039) + (0.829 - 0.057) )/ 2 )
=-5.468/( ( 1.068 + 0.772 )/ 2 )
=-5.468/0.92
=-594.35 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -594.35% mean?
Lir Life Sciences (BBCMF) has a ROCE % of -594.35% as of Jan. 2026.
Is Lir Life Sciences' ROCE % too high?
Lir Life Sciences' current ROCE % is -594.35%. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' ROCE % compare to VRTX and REGN?
Lir Life Sciences' ROCE % of -594.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Lir Life Sciences's current ROCE % is -594.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current ROCE % of -594.35%. The current ROCE % is -594.35%. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current ROCE % is -594.35% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price